ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,585,000 | +58.8% | 65,000 | -7.1% | 0.04% | -7.1% |
| Q4 2018 | $998,000 | -40.5% | 70,000 | -36.6% | 0.04% | -4.5% |
| Q3 2018 | $1,678,000 | -16.7% | 110,375 | -8.0% | 0.04% | -8.3% |
| Q2 2018 | $2,014,000 | -11.9% | 120,000 | -14.3% | 0.05% | -33.3% |
| Q1 2018 | $2,285,000 | +2.0% | 140,000 | -20.0% | 0.07% | +24.1% |
| Q4 2017 | $2,240,000 | +5.6% | 175,000 | +1.4% | 0.06% | -26.6% |
| Q3 2017 | $2,122,000 | +81.1% | 172,500 | +23.2% | 0.08% | +61.2% |
| Q2 2017 | $1,172,000 | -6.4% | 140,000 | 0.0% | 0.05% | -2.0% |
| Q1 2017 | $1,252,000 | +5.5% | 140,000 | +3.7% | 0.05% | -13.8% |
| Q4 2016 | $1,187,000 | +30.3% | 135,000 | 0.0% | 0.06% | +3.6% |
| Q3 2016 | $911,000 | +80.0% | 135,000 | -5.0% | 0.06% | +43.6% |
| Q2 2016 | $506,000 | -28.5% | 142,155 | -40.8% | 0.04% | +25.8% |
| Q1 2016 | $708,000 | -30.1% | 240,000 | 0.0% | 0.03% | -55.7% |
| Q4 2015 | $1,013,000 | -3.4% | 240,000 | +4.3% | 0.07% | +52.2% |
| Q3 2015 | $1,049,000 | -29.7% | 230,000 | +11.1% | 0.05% | -22.0% |
| Q2 2015 | $1,492,000 | -2.0% | 207,000 | +0.2% | 0.06% | -13.2% |
| Q1 2015 | $1,522,000 | +60.9% | 206,500 | +3.2% | 0.07% | +106.1% |
| Q4 2014 | $946,000 | +29.2% | 200,000 | -2.4% | 0.03% | +83.3% |
| Q3 2014 | $732,000 | -13.3% | 205,000 | +10.8% | 0.02% | 0.0% |
| Q2 2014 | $844,000 | +23.8% | 185,000 | +27.6% | 0.02% | +28.6% |
| Q1 2014 | $682,000 | -25.7% | 145,000 | -20.8% | 0.01% | -30.0% |
| Q4 2013 | $918,000 | -63.1% | 183,150 | -54.2% | 0.02% | -25.9% |
| Q3 2013 | $2,488,000 | +110.8% | 400,000 | +53.8% | 0.03% | -20.6% |
| Q2 2013 | $1,180,000 | – | 260,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |